IP Library Granted Patent US 9,181,586
Granted Patent B2
US 9,181,586 · App. 13/714,242 · Granted Nov 10, 2015

Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms

Inventors: Aoy Tomita Mitchell (Elm Grove, WI); Michael Mitchell (Elm Grove, WI)
Assignee: University of Louisville Research Foundation, Inc.
C12Q1/6883C12Q2600/156C12Q2600/172Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,181,586
App. No.
13/714,242
Granted
Nov 10, 2015
Kind
B2
Abstract

The invention provides tandem single nucleotide polymorphisms and methods for their use, for example, in diagnosing Down Syndrome.

Claims (15)

1. A method for determining whether a fetus has a trisomy, said method comprising:

obtaining fetal and maternal cell-free DNA from maternal blood;

using a computer implementation of a mathematical algorithm, designing primers to amplify target sequences comprising tandem SNPs on selected chromosomes in the fetal and maternal cell-free DNA;

using the designed primers, amplifying the target sequences comprising tandem SNPs to produce amplicons from the cell-free DNA from maternal blood;

sequencing the amplicons using high-throughput sequencing;

identifying the tandem SNPs by comparing the sequenced amplicons to a reference sequence;

determining heterozygosity of the tandem SNPs for each of the selected chromosomes;

identifying target sequences exhibiting three haploytpes of at least one tandem SNP, wherein at least one of said haplotypes is not present in the maternal DNA;

comparing the three haplotypes by determining the relative copy number of each of the haplotypes; and

determining that the fetus has a trisomy based on the relative copy number of the three haplotypes.

2. The method of claim 1 , wherein the amplification is accomplished by high-fidelity PCR.

3. The method of claim 1 , wherein the high-throughput sequencing is at a single molecule level.

4. The method of claim 1 , wherein comparing the sequenced amplicons requires a substantial identity between the amplicons of at least 95%.

5. The method of claim 1 , wherein comparing the sequenced amplicons requires a substantial identity between the amplicons of at least 98%.

6. The method of claim 1 , wherein comparing the sequenced amplicons requires a substantial identity between the amplicons of at least 99%.

Continuity (4)
Continuation In Part 12850588 · Aug 4, 2010
Continuation 11713069 · Feb 28, 2007
Provisional Application 60777865 · Feb 28, 2006
Related Publication 20130231252A1 · Sep 5, 2013